Close | Chg | Chg % |
---|---|---|
$335.39 | 6.00 | 1.82% |
Company | Symbol | Total Net Assets |
---|---|---|
Abbott Laboratories | ABT | 14.53% |
Thermo Fisher Scientific Inc. | TMO | 13.40% |
Medtronic PLC | MDT | 9.94% |
Danaher Corp. | DHR | 8.18% |
Becton Dickinson & Co. | BDX | 4.62% |
Intuitive Surgical Inc. | ISRG | 4.20% |
Stryker Corp. | SYK | 3.97% |
Edwards Lifesciences Corp. | EW | 3.87% |
Boston Scientific Corp. | BSX | 3.81% |
IDEXX Laboratories Inc. | IDXX | 3.07% |
Category | Health/Biotech |
Portfolio Style | Health/Biotech |
Fund Status | Open |
Fund Inception | May 1, 2006 |
Manager |
Team Managed
|
The Fund seeks to track the investment results of the Dow Jones US Select Medical Equipment Index composed of US equities in the medical devices sector. The Fund invests at least 90% of its assets in securities of the Underlying Index and in depositary receipts representing securities of the Underlying Index.
Date | Income Distribution |
---|---|
YTD | - |
2020 | $0.81 |
2019 | $0.88 |
2018 | $0.53 |
2017 | $0.64 |
2016 | $0.73 |
2015 | $1.57 |
2014 | $0.73 |
2013 | $0.30 |
2012 | $0.43 |
2011 | $0.16 |